CSLLY
Csl ADR

80
Loading...
Loading...
News
all
press releases
News Placeholder
Australia’s CSL hits 6-wk high on report of R&D division job cuts
Investing.com-- Shares of Australia’s CSL Ltd (ASX:CSL) climbed over 3% on Tuesday after the Australian Financial Review reported the biotech giant is planning to cut around one-third of its roughly 2,500-strong global R&D workforce.
investing.com·2mo ago
News Placeholder
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
ALKS vs. CSLLY: Which Stock Is the Better Value Option?
Zacks·3mo ago
News Placeholder
KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now?
Zacks·4mo ago
News Placeholder
CSL lifts HY profit as plasma sales jump, offsets flu vaccine weakness
Investing.com-- Australian biopharmaceutical giant CSL Ltd (ASX:CSL) reported a rise in half-year net profit, driven primarily by robust performance in its blood plasma division.
investing.com·7mo ago

Latest CSLLY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.